Detoxification and liver health are essential aspects of overall well-being, and their optimization can significantly improve patients' quality of life. iollo's advanced metabolomic testing offers healthcare providers a powerful tool to identify imbalances in detoxification pathways and liver function, enabling the development of personalized interventions for their patients. This educational material aims to familiarize physicians with the key detoxification and liver health markers measured by iollo's test, their interpretation, and the potential benefits for patients concerned about toxin exposure and liver health.
iollo's detoxification and liver health testing can be particularly beneficial for patients experiencing various symptoms or conditions related to impaired detoxification or liver dysfunction. Some of the key indications for testing include:
Other patients who may benefit from detoxification and liver health testing include those with a history of heavy alcohol use, exposure to environmental toxins, or taking medications that may burden the liver.
iollo's Detoxification and Liver Health Panel measures a comprehensive set of biomarkers that provide insights into various aspects of detoxification pathways and liver function. Some of the key markers include:
iollo's metabolomic testing provides valuable insights into patients' detoxification and liver health status:
iollo's test results are highly actionable, offering personalized recommendations based on each patient's unique health history and context:
Physicians can assist patients in prioritizing 2-3 key recommendations to focus on initially, based on the most significant imbalances in detoxification and liver health markers and the patient's individual goals and preferences. Regular monitoring of these biomarkers can also help track patients' progress and optimize their treatment plans over time.
iollo's advanced metabolomic testing provides healthcare providers with a powerful tool to assess and optimize their patients' detoxification and liver health. By understanding the key markers measured and their implications for detoxification pathways and liver function, physicians can develop personalized interventions that address underlying imbalances and support their patients' well-being. Integrating Iollo's testing into clinical practice can complement other functional and integrative approaches to detoxification and liver support, ultimately helping patients achieve optimal health outcomes.
To learn more about iollo's metabolomic testing and how it can benefit your patients, please visit www.iollo.com or contact our support team at [email protected].
[1] Guzior & Quinn (2021). Microbiome. 9(1):1-13.
[2] Azer & Hasanato (2021). Medicine. 100(41).
[3] Liu et al. (2019). Exp Ther Med. 18(5):4058-4066.
[4] Fischer et al. (1976). Surgery. 80(1):77-91.
[5] Tajiri & Shimizu (2013). World J Gastroenterol. 19(43):7620-7629.
[6] Ishikawa (2012). World J Gastroenterol. 18(17):2005-2010.
[7] Procházková et al. (2023). Gut. 72(1):180-191.
[8] Lynch & Adams (2014). Nat Rev Endocrinol. 10(12):723-36.